viernes, 24 de abril de 2026

Effect of Uplizna (Inebilizumab) on Ocular Manifestations in Myasthenia Gravis by Madaline Spencer| Published on: Apr 24, 2026

Effect of Uplizna (Inebilizumab) on Ocular Manifestations in Myasthenia Gravis by Madaline Spencer| Published on: Apr 24, 2026 Richard J. Nowak, MD, global principal MINT investigator and director of the Myasthenia Gravis Clinic at Yale University, discusses a post-hoc analysis of Uplizna (inebilixumab) on the effect of ocular manifestations in generalized myasthenia gravis (gMG). https://checkrare.com/effect-of-uplizna-inebilizumab-on-ocular-manifestations-in-myasthenia-gravis/

No hay comentarios:

Publicar un comentario